Detection of streptococcal class I M protein in psoriasis by confocal immnunofluorescent microscopy

Acta Dermato-Venereologica

Volumn 77, Issue 3, 1997, Pages 175-180

  Talanin, Nickolai Y ^a   Shelley, Walter B ^a   Raeder, Roberta ^a   Shelley, E Dorinda ^a   Boyle, Michael D P ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

focal infection; Streptococcus pyogenes antigen antibody

Indexed keywords

M PROTEIN; MONOCLONAL ANTIBODY; STREPTOCOCCUS ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; CARRIER PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOCAL INFECTION; HAIR FOLLICLE; HUMANS; MICROSCOPY, CONFOCAL; PSORIASIS; STREPTOCOCCUS PYOGENES;

EID: 0030949523     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Norrlind R. Psoriasis following infections with haemolytic streptococci. Acta Derm Venereol (Stockh) 1950; 30: 64-72.
2. Norholm-Pederson A. Infections and psoriasis. Acta Derm Venereol (Stockh) 1952; 32: 159-167.
3. Teranishi Y, Mizutani H, Murata M, Shimizu M, Matsushima K. Increased spontaneous production of IL-8 in peripheral blood monocytes from the psoriatic patient: relation to focal infection and response to treatments. J Dermatol Sci 1995; 10: 8-15.
4. Barker JNWN. The pathophysiology of psoriasis. Lancet 1991; 338: ii: 227-230.
5. Cohen Tervaert WC, Esseveld H. A study of the incidence of haemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica 1970; 140: 282-290.
6. Swerlick RA, Cunningham MW, Hall NK. Monoclonal antibodies cross-reactive with group A streptococci and normal and psoriatic human skin. J Invest Dermatol 1986; 87: 367-371.
7. McFadden J, Valdimarsson H, Fry L. Cross-reactivity between streptococcal M surface antigen and human skin. Br J Dermatol 1991; 125: 443-447.
8. Shelley WB, Talanin N, Shelley ED, Freimer EH. Occult Streptococcus pyogenes in cellulitis: demonstration by immunofluorescence. Br J Dermatol 1995; 132: 989-991.
9. Shelley WB. Epidermal surgery. J Dermatol Surg 1976; 2: 125-128.
10. Raeder R, Otten RA, Chamberlin L, Boyle MDP. Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol 1992; 30: 3074-3081.
11. Boyle MDP, Raeder R. Analysis of heterogeneity of IgG-binding proteins expressed by group A streptococci. ImmunoMethods 1993; 2: 41-53.
12. Boyle MDP, Weber-Heynemann J, Raeder R, Podbielski A. Characterization of a gene coding for a type IIo bacterial IgG-binding protein. Mol Immunol 1995; 32: 669-678.
13. Bessen D, Jones KF, Fischetti VA. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 1989; 169: 269-283.
14. Podbielsky A, Flosdorff A, Weber-Heynemann J. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes. Infect Immun 1995; 63: 9-20.
15. Boyle MDP, Hawlitzky J, Raeder R, Podbielski A. Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate. Infect Immun 1994; 62: 1336-1347.
16. Raeder R, Boyle MDP. Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J Infect Dis 1996; 173 (In print).
17. Jones KF, Khan SA, Erickson BW, Hollingshead SK, Scott JR, Fischetti VA. Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med 1986; 164: 1226-1238.
18. 389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Medicine 1995; 1: 442-447.
19. Fry L. Psoriasis. Br J Dermatol 1988; 119: 445-461.
20. Rosenberg EW, Noah PW. The Koebner phenomenon and the microbial basis of psoriasis. J Am Acad Dermatol 1988; 18: 151-158.
21. Shelley WB, Wood MG, Beerman H. Pustular psoriasis elicited by streptococcal antigen and localized to the sweat pore. J Invest Dermatol 1975; 65: 466-471.
22. Baker BS, Bokth S, Powles A, Garioch JJ, Lewis H, Valdimarsson H, Fry L. Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesions. Br J Dermatol 1993; 128: 493-499.
23. Nickoloff BJ, Mitra RS, Green J, Shimizu Y, Thompson C, Turka LA. Activated keratinocytes present bacterial-derived superantigens to T lymphocytes: relevance to psoriasis. J Dermatol Sci 1993; 6: 127-133.
24. Valdimarsson H, Baker BS, Jonsdottis I, Powels A, Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16: 145-149.
25. Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey EH, Dale JB. Human and murine antibodies crossreactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 1989; 143: 2677-2683.
26. Colman G, Tanna A, Efstratiou A, Gaworzewska ET. The serotypes of Streptococcus pyogenes present in Britain during 1980 1990 and their association with disease. J Med Microbiol 1993; 39: 165-178.
27. Okada N, Liszewski MK, Atkinson JP, Caparon M. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci USA 1995; 92: 2489-2493.
28. Okada N, Pentland AP, Falk P, Caparon MG. M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest 1994; 94: 965-977.
29. Tabata T. The concept of focal infection of tonsil. Adv Otorhinolaryngol 1992; 47: 193-195.
30. Boehncke WH, Wortmann S, Kaufmann R, Mielke V, Sterry W. A subset of macrophages located along the basement membrane ("lining cells") is a characteristic histopathologic feature of psoriasis. Am J Dermatopathol 1995; 17: 139-144.
31. LaPenta D, Rubens C, Chi E, Cleary PP. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci USA 1994; 91: 12115-12119.
32. Ohanian SH, Schwab JH. Persistence of group A streptococcal cell walls related to chronic inflammation of rabbit dermal connective tissue. J Exp Med 1967; 125: 1137-1148.
33. Raeder R, Boyle MDP. Association between expression of immunoglobulin G-binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun 1993; 61: 1378-1384.
34. Fischetti VA, Horstmann RD, Pancholi V. Location of the complement factor H binding site on streptococcal M6 protein. Infect Immun 1995; 63: 149-153.
35. Pruksakorn S, Currie B, Brandt E, Phornphutkul C, Hunsakunachai S, Manmontri A, et al. Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol 1994; 6: 1235-1244.
36. Shelley ED. Bacterial and fungal infections affecting psoriasis. Jap J Dermatol 1981; 91: 1642-1645.
37. Rosenberg EW, Noah PW, Skinner RB. Psoriasis is a visible manifestation of the skin's defense against micro-organisms. J Dermatol 1994; 21: 375-381.
38. Rook GAW, Stanford JL. Slow bacterial infections or autoimmunity? Immunol Today 1992; 13: 160-164.